Haukeland University Hospital is a hospital in Bergen, Norway, and one of the eleven institutions that make up Bergen Hospital Trust.

There are 1,100 beds in Department of Oncology, Haukeland University Hospital.

During the past decade, Department of Oncology, Haukeland University Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology, Haukeland University Hospital" #1 collaborator was "Oslo University Hospital" with 2 trials as a collaborator, "The Kavli Foundation" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Department of Oncology, Haukeland University Hospital" are "Chronic Fatigue Syndrome" (3 trials), "Myalgic Encephalomyelitis" (2 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials) and "Chronic Fatigue Syndrome (CFS)" (1 trials). Many other conditions were trialed in "Department of Oncology, Haukeland University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Oncology, Haukeland University Hospital" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma" (1 trials), "Bevacizumab" (1 trials), "Cetuximab (Erbitux)" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Oncology, Haukeland University Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Department of Oncology, Haukeland University Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Department of Oncology, Haukeland University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Oncology, Haukeland University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".